Method for treating a rheumatic disease using a soluble TLA4 molecule
US8148332B2 · kind B2 · utility
8Cited by
49References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 27, 2011 |
| Grant date | Apr 3, 2012 |
| Priority date | — |
| Expiry date | Jul 27, 2031 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to compositions and methods for treating rheumatic diseases, such as psoriasis arthropathica, by administering to a subject a CTLA4 molecule that block endogenous B7 molecules from binding their ligands.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.